About Us 🔊 New Interview – Inside Cardiawave’s Journey with the EIC Scaling Club🎙️ Cardiawave’s presentation at LSI 2025 Jan 13, 2026 HeleneCardiawave 0
Press Release VALVOSOFT®, the first non-invasive treatment for severe Symptomatic Aortic Stenosis (sSAS) from Cardiawave receives CE Marking Dec 4, 2025 HeleneCardiawave 0
Press Release VALVOSOFT®, le premier traitement non invasif de la Sténose Aortique Sévère symptomatique (sSAS) développé par Cardiawave, obtient le marquage CE Dec 4, 2025 HeleneCardiawave 0
Events 📢 Cardiawave’s Valvosoft® to be presented at PCR London Valves 2025! Nov 6, 2025 HeleneCardiawave 0
Press Release Cardiawave renforce son leadership avec la nomination de Jonathan Freeman, Président du CA Oct 30, 2025 HeleneCardiawave 0
About UsArticle Top Santé: “Valves calcifiées…Des ultrasons pour les assouplir” Jul 15, 2024 READ MORE
EventsGroundbreaking presentation at the Cardio World Congress 2024 by Dr Danijela Trifunovic ! Jul 3, 2024 READ MORE
About Us 🔊 New Interview – Inside Cardiawave’s Journey with the EIC Scaling Club🎙️ Cardiawave’s presentation at LSI 2025 Jan 13, 2026 HeleneCardiawave 0
Press Release VALVOSOFT®, the first non-invasive treatment for severe Symptomatic Aortic Stenosis (sSAS) from Cardiawave receives CE Marking Dec 4, 2025 HeleneCardiawave 0
Press Release VALVOSOFT®, le premier traitement non invasif de la Sténose Aortique Sévère symptomatique (sSAS) développé par Cardiawave, obtient le marquage CE Dec 4, 2025 HeleneCardiawave 0
Events 📢 Cardiawave’s Valvosoft® to be presented at PCR London Valves 2025! Nov 6, 2025 HeleneCardiawave 0
Press Release Cardiawave renforce son leadership avec la nomination de Jonathan Freeman, Président du CA Oct 30, 2025 HeleneCardiawave 0
